External Advisory Board reviews progress towards Comprehensive Cancer Center designation

The External Advisory Board (EAB) for The University of Kansas Cancer Center submitted their most recent report evaluating cancer research programs and providing recommendations for steps needed to obtain Comprehensive Cancer Center designation in 2017.

"Based on the plan you have put in place, the high level of institutional support for strengthening clinical research, and the amount of time between now and submission of your competitive renewal proposal, we believe that Comprehensive designation should remain a goal for that submission," said George Weiner, M.D., chair of the EAB.

The EAB, comprised of top cancer researchers from across the U.S., suggested KU Cancer Center's primary focus should continue to be on strengthening clinical investigation.

Other recommendations include:

  • recruiting clinical investigators and other physician scientists to the Division of Hematology/Oncology in the Department of Internal Medicine and recruitment of a new director of that division
  • demonstrating how research impacts KU Cancer Center's catchment area, especially population science, cancer control and cancer prevention research that uses the Midwest Cancer Alliance (MCA)to impact important catchment area problems
  • increasing clinical trial participation; accrual to investigator-initiated trials is particularly important
  • demonstrating both the ability to generate new novel compounds as well as to take these through drug development
  • exploring innovative approaches to establish fully integrated collaborations involving multi-disciplinary team members
  • developing multiĀ­investigator projects and grant applications to foster collaborative team science

The EAB praised all four of KU Cancer Center's research program areas as well as recognizing the progress of the Clinical Trials Office infrastructure and clinical research, and the clinical value the MCA brings to the people of Kansas.

"We are just two years away from applying for Comprehensive Cancer Center designation and, while we are pleased with the EAB's positive comments, we have a lot of work to do by September of 2016," said Roy Jensen, M.D., director of the KU Cancer Center. "I have no doubt that with the great team we continue to assemble, we will be ready."


Request an Appointment

913-588-1227


Toll Free

844-323-1227


Clinical Trials

Clinical trials can give you access to potentially effective new drugs, therapies and diagnostic tools in research.

Let us match you to an open trial. Contact our clinical trials nurse navigator, 913-945-7552.